Public Health News and Research

RSS

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.

16 Jul 2010

Rapid weight loss the best: Study

Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.

15 Jul 2010

8.8% of drug-related hospital emergency department visits by adolescents is a suicide attempt

A new series of studies analyzing drug-related hospital emergency department visits throughout the country during 2008 reveals a substantial percentage of these visits involve suicide attempts. According to these studies conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) more than one in every twelve (8.8 percent) drug-related hospital emergency department visit by an adolescent is a suicide attempt - double the rate found among cases involving those age 25 and older (4.4 percent).

15 Jul 2010

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.

15 Jul 2010

NVHR welcomes national HIV/AIDS strategy that recognizes better care for HIV/AIDS, viral hepatitis patients

With millions of Americans living with HIV/AIDS, chronic viral hepatitis, or a combination of both, the National Viral Hepatitis Roundtable welcomes the Administration's recognition of the need for better care coordination and integration of services for these individuals and supports recommendations contained within the new National HIV/AIDS strategy released yesterday in Washington.

15 Jul 2010

Study looks at trans fat trends in major fast food chains

Five major fast food chains have significantly decreased trans fats in the oils they use to cook food, according to new research from the University of Minnesota School of Public Health.

15 Jul 2010

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.

15 Jul 2010

Expert panel convened to discuss new ways to prevent global aging crisis

Now that scientists have learned so much about aging through laboratory studies, it's time to translate those findings into medicines that can benefit our aging population. That was the message delivered by a panel of 10 preeminent aging experts that included Jan Vijg, Ph.D., chair of genetics and the Lola and Saul Kramer Chair in Molecular Genetics at Albert Einstein College of Medicine of Yeshiva University.

15 Jul 2010

UNC research to be presented at International AIDS Society conference

Dozens of UNC researchers are heading to Vienna, Austria to participate in the world's preeminent AIDS conference this week. The International AIDS Society conference brings together top scientists, advocates and government officials to discuss progress and chart a course for stemming the spread and impact of AIDS. Speakers including President Bill Clinton will address an estimated 25,000 attendees at this year's event.

15 Jul 2010

Researchers issue a call to improve prevention, treatment of osteoporosis

A comprehensive Argentinean epidemiological study reveals the staggering costs of osteoporosis in the country.

15 Jul 2010

MRI, University of Minnesota SPH enter agreement to further research collaboration

The Medica Research Institute (MRI) and the University of Minnesota School of Public Health (SPH) have entered into an agreement to jointly search for a senior director of the MRI who will also hold an adjunct faculty position at the SPH. The Medica Research Institute was established in January 2010 to conduct research that can be translated into activities that protect health and improve lives.

15 Jul 2010

Obese people prefer non-commercial, non-stigmatizing techniques for lifestyle-change interventions

Obese people support lifestyle-change interventions, rather than those that purely promote weight loss. Researchers writing in BioMed Central's open access journal BMC Public Health interviewed 142 obese people about their opinions on interventions ranging from gastric bands to legal regulation, finding that non-commercial, non-stigmatizing techniques were preferred.

15 Jul 2010

Chief Medical Officer of Cook County Health & Hospitals System receives CARES Award

Terry Mason, M.D., Chief Medical Officer of the Cook County Health & Hospitals System, received the first annual Resurrection Health Care C.A.R.E.S. Award July 12 for his many contributions to the community.

15 Jul 2010

New myopia control technology for eye health benefits from Vision CRC

Scientists from the Vision Cooperative Research Centre in Australia have announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners – the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

15 Jul 2010

Children with highest levels of FeNO more likely to develop asthma: Study

Children with elevated levels of exhaled nitric oxide are at increased risk for developing asthma, particularly among children without a parental history of the disease, a study by US researchers at the Keck School of Medicine of the University of Southern California (USC) has found. The study is published ahead of print in the European Respiratory Journal.

15 Jul 2010

Final rules for e-health rewards unveiled

The federal government has issued new regulations defining the "meaningful use" of electronic medical records, a requirement doctors must fulfill in order to gain funds from a $27-billion pot set aside in the 2009 stimulus law, The New York Times reports. "A doctor can receive up to $44,000 under Medicare and $63,750 under Medicaid, while a hospital can receive millions of dollars, depending on its size."

15 Jul 2010

Aboriginals smoke less cigarettes per day than others: Study

A new study showed that Aboriginal smokers residing in remote communities have a significantly lower consumption of cigarettes than the rest of the population. The study was published in the Australian and New Zealand Journal of Public Health on Wednesday.

14 Jul 2010

NIAID awards ATCC multimillion dollar MID-BRR contract

ATCC, the premier biological materials resource, services, and standards organization, has been awarded the National Institute of Allergy and Infectious Diseases, Microbiology and Infectious Diseases Biological Resource Repository ("MID-BRR") contract, ATCC announced today. The current value of the contract is $14,615,598 with the ultimate value of $115,733,409 over 7 years with an annual renewal.

14 Jul 2010

Maven Semantic announces updates to database of Toxicology researchers

Maven Semantic announces updates to their Toxicology database.

14 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

Public Health News and Research

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

Rapid weight loss the best: Study

8.8% of drug-related hospital emergency department visits by adolescents is a suicide attempt

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NVHR welcomes national HIV/AIDS strategy that recognizes better care for HIV/AIDS, viral hepatitis patients

Study looks at trans fat trends in major fast food chains

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Expert panel convened to discuss new ways to prevent global aging crisis

UNC research to be presented at International AIDS Society conference

Researchers issue a call to improve prevention, treatment of osteoporosis

MRI, University of Minnesota SPH enter agreement to further research collaboration

Obese people prefer non-commercial, non-stigmatizing techniques for lifestyle-change interventions

Chief Medical Officer of Cook County Health & Hospitals System receives CARES Award

New myopia control technology for eye health benefits from Vision CRC

Children with highest levels of FeNO more likely to develop asthma: Study

Final rules for e-health rewards unveiled

Aboriginals smoke less cigarettes per day than others: Study

NIAID awards ATCC multimillion dollar MID-BRR contract

Maven Semantic announces updates to database of Toxicology researchers

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

News Medical 2025: Healthcare Shifts That Mattered Most eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News